1. Home
  2. REPL vs ESQ Comparison

REPL vs ESQ Comparison

Compare REPL & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • ESQ
  • Stock Information
  • Founded
  • REPL 2015
  • ESQ 2006
  • Country
  • REPL United States
  • ESQ United States
  • Employees
  • REPL 479
  • ESQ N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • REPL Health Care
  • ESQ Finance
  • Exchange
  • REPL Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • REPL 239.0M
  • ESQ 756.3M
  • IPO Year
  • REPL 2018
  • ESQ 2017
  • Fundamental
  • Price
  • REPL $3.15
  • ESQ $98.65
  • Analyst Decision
  • REPL Buy
  • ESQ Hold
  • Analyst Count
  • REPL 10
  • ESQ 3
  • Target Price
  • REPL $8.25
  • ESQ $103.00
  • AVG Volume (30 Days)
  • REPL 9.2M
  • ESQ 166.8K
  • Earning Date
  • REPL 08-07-2025
  • ESQ 07-24-2025
  • Dividend Yield
  • REPL N/A
  • ESQ 0.71%
  • EPS Growth
  • REPL N/A
  • ESQ 12.45
  • EPS
  • REPL N/A
  • ESQ 5.39
  • Revenue
  • REPL N/A
  • ESQ $126,841,000.00
  • Revenue This Year
  • REPL N/A
  • ESQ N/A
  • Revenue Next Year
  • REPL N/A
  • ESQ $10.72
  • P/E Ratio
  • REPL N/A
  • ESQ $18.24
  • Revenue Growth
  • REPL N/A
  • ESQ 12.91
  • 52 Week Low
  • REPL $2.68
  • ESQ $54.49
  • 52 Week High
  • REPL $17.00
  • ESQ $106.11
  • Technical
  • Relative Strength Index (RSI)
  • REPL 24.82
  • ESQ 52.48
  • Support Level
  • REPL $2.68
  • ESQ $95.09
  • Resistance Level
  • REPL $3.85
  • ESQ $101.28
  • Average True Range (ATR)
  • REPL 0.80
  • ESQ 3.51
  • MACD
  • REPL -1.03
  • ESQ 0.05
  • Stochastic Oscillator
  • REPL 4.45
  • ESQ 32.29

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: